AstraZeneca PLC (AZN.L)
AZN.L on London Stock Exchange
5,229.00GBp
22 Jun 2018
5,229.00GBp
22 Jun 2018
Change (% chg)
-26.00 (-0.49%)
-26.00 (-0.49%)
Prev Close
5,255.00
5,255.00
Open
5,236.00
5,236.00
Day's High
5,236.00
5,236.00
Day's Low
5,194.00
5,194.00
Volume
2,045,106
2,045,106
Avg. Vol
1,979,884
1,979,884
52-wk High
5,585.07
5,585.07
52-wk Low
4,260.00
4,260.00
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Mar '18 | 5,178.00 | 0.268 |
| FY 2017 | Dec '17 | 5,777.00 | 1.048 |
| Sep '17 | 6,232.00 | 0.541 | |
| Jun '17 | 5,051.00 | 0.376 | |
| Mar '17 | 5,405.00 | 0.424 | |
| FY 2016 | Dec '16 | 5,585.00 | 1.455 |
| Sep '16 | 5,699.00 | 0.801 | |
| Jun '16 | 5,603.00 | -0.002 | |
| Mar '16 | 6,115.00 | 0.511 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 11 | 5,397.27 | 5,632.60 | 5,054.58 | 5,378.78 |
| Quarter Ending Sep-18 | 11 | 5,666.90 | 6,075.11 | 5,343.00 | 5,385.24 |
| Year Ending Dec-18 | 31 | 22,361.00 | 23,199.00 | 20,818.00 | 22,298.80 |
| Year Ending Dec-19 | 31 | 23,874.00 | 26,486.00 | 21,913.00 | 24,121.40 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 10 | 0.83 | 1.07 | 0.59 | 0.64 |
| Quarter Ending Sep-18 | 10 | 0.86 | 0.99 | 0.65 | 0.85 |
| Year Ending Dec-18 | 32 | 3.37 | 3.79 | 2.41 | 3.82 |
| Year Ending Dec-19 | 33 | 3.89 | 4.94 | 3.03 | 4.42 |
| LT Growth Rate (%) | 6 | 9.91 | 16.70 | 3.70 | 6.08 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 22.12 | 30.95 | 32.74 | |
| P/E High - Last 5 Yrs. | 72.73 | 40.70 | 45.73 | |
| P/E Low - Last 5 Yrs. | 9.58 | 23.63 | 24.23 | |
| Beta | 1.04 | 0.89 | 0.88 | |
| Price to Sales (TTM) | 3.94 | 3.94 | 5.71 | |
| Price to Book (MRQ) | 6.27 | 4.81 | 5.37 | |
| Price to Tangible Book (MRQ) | -- | 5.61 | 6.94 | |
| Price to Cash Flow (TTM) | 13.70 | 22.91 | 23.32 | |
| % Owned Institutions | -- | 1.21 | 2.17 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.56 | 1.50 | |
| Dividend Yield - 5 Year Avg | 5.55 | 1.57 | 1.51 | |
| Dividend 5 Year Growth Rate | 4.86 | 4.47 | 5.32 | |
| Payout Ratio(TTM) | 62.12 | 45.35 | 43.29 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -9.85 | 2.24 | 7.89 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -9.65 | 4.83 | 5.68 | |
| Sales - 5 Yr. Growth Rate | -7.29 | 10.08 | 10.33 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 15,985.23 | 16.38 | 19.38 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 74.09 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -17.55 | 9.88 | 10.78 | |
| Capital Spending - 5 Yr. Growth Rate | 12.28 | 15.52 | 15.47 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 0.73 | 2.12 | 2.19 |
| Current Ratio (MRQ) | 0.91 | 2.90 | 2.98 |
| LT Debt to Equity (MRQ) | 122.99 | 9.88 | 12.19 |
| Total Debt to Equity (MRQ) | 144.47 | 13.86 | 16.46 |
| Interest Coverage (TTM) | 4.61 | 35.89 | 32.81 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 82.88 | 54.81 | 54.46 | |
| Gross Margin - 5 Yr. Avg. | 80.69 | 52.15 | 52.22 | |
| EBITD Margin (TTM) | 38.95 | -- | -- | |
| EBITD - 5 Yr. Avg | 31.99 | 18.57 | 10.98 | |
| Operating Margin (TTM) | 24.85 | 14.36 | 4.74 | |
| Operating Margin - 5 Yr. Avg. | 17.97 | 14.52 | 6.41 | |
| Pre-Tax Margin (TTM) | 18.09 | 14.82 | 5.58 | |
| Pre-Tax Margin - 5 Yr. Avg. | 14.67 | 14.91 | 6.83 | |
| Net Profit Margin (TTM) | 17.34 | 11.08 | 1.88 | |
| Net Profit Margin - 5 Yr. Avg. | 12.74 | 11.20 | 3.10 | |
| Effective Tax Rate (TTM) | 4.14 | 23.16 | 23.04 | |
| Effective Tax Rate - 5 Yr. Avg. | 13.16 | 23.42 | 23.95 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 278,767 | 938,104,300 | 846,855,748 | |
| Net Income/Employee (TTM) | 48,342 | 110,371,256 | 99,619,396 | |
| Receivable Turnover (TTM) | 4.36 | 5.63 | 5.78 | |
| Inventory Turnover (TTM) | 1.40 | 2.59 | 3.35 | |
| Asset Turnover (TTM) | 0.34 | 0.95 | 0.92 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 5.82 | 11.40 | 10.95 | |
| Return on Assets - 5 Yr. Avg. | 5.71 | 12.91 | 12.32 | |
| Return on Investment (TTM) | 7.86 | 14.84 | 14.38 | |
| Return on Investment - 5 Yr. Avg. | 7.89 | 16.88 | 16.11 | |
| Return on Equity (TTM) | 28.47 | 16.34 | 16.08 | |
| Return on Equity - 5 Yr. Avg. | 15.71 | 17.98 | 17.41 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -6.90 | -3.76 | -7.29 |
| EPS (TTM) % | 23.76 | 10.68 | -17.55 |
| Dividend % | 26.80 | 8.24 | 4.86 |
Note: Units in Millions of US Dollars
Performance for AstraZeneca PLC
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 7.60 | 5.39 | 99 | 25 |
| 13 Week | 0.47 | -2.14 | 99 | 35 |
| 26 Week | 7.52 | 4.45 | 99 | 29 |
| 52 Week | 2.55 | -5.39 | 99 | 12 |
| YTD | 16.15 | 8.98 | 99 | 25 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 53.14% |
| # of Holders: | 581 |
| Total Shares Held: | 673,117,968 |
| 3 Mo. Net Change: | -11,640,759 |
| # New Positions: | 31 |
| # Closed Positions: | 30 |
| # Increased Positions: | 166 |
| # Reduced Positions: | 179 |
| # Net Buyers: | -13 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
- What does AstraZeneca plc's deal with Pfizer mean for shareholders?
- Is Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today’s update?
- 3 stocks to help you retire early
- Is it time to take profits on GlaxoSmithKline plc and AstraZeneca plc?
- These FTSE 100 stars have exploded in Q3! And they're not finished yet
- Why now is the perfect time to buy these 3 super income stocks